by Dolly the Sheep | Jun 24, 2026 | Disease Modelling, Drug Discovery, Immunology, in vivo Studies
ARTICLE BY BIO X CELL Emerging Therapeutic Strategies in Cancer Research Bio X Cell has recently published a comprehensive piece titled “Emerging Therapeutic Strategies in Cancer Research.” Oncology is transitioning into a new era defined by precision, biological...
by Dolly the Sheep | Jun 24, 2026 | Disease Modelling, Drug Discovery, Immunology, in vivo Studies
ARTICLE BY BIO X CELL Bio X Cell Introduces First Commercially Available Anti-Mouse Trispecific Antibody for Preclinical Research Bio X Cell has announced the launch of the first commercially available, ready-to-use anti-mouse PD-L1 × TIGIT × LAG3 trispecific antibody...
by Dolly the Sheep | Jun 24, 2026 | Disease Modelling, Drug Discovery, Immunology, in vivo Studies
ARTICLE BY BIO X CELL The Reproducibility Crisis Is a Reagent Crisis For more than a decade, concerns regarding scientific reproducibility have echoed across funding agencies, academic journals, and research laboratories worldwide. While investigators typically...
by Dolly the Sheep | Jun 24, 2026 | Disease Modelling, Drug Discovery, Immunology, in vivo Studies
ARTICLE BY BIO X CELL How Fc Engineering Improves Mechanistic Clarity in In Vivo Studies Bio X Cell has recently published a highly informative piece titled “How Fc Engineering Improves Mechanistic Clarity in In Vivo Studies.” As researchers transition their work from...
by Dolly the Sheep | Jun 1, 2026 | Company News, LAB-A-PORTER Insiders, News
POST-EVENT UPDATE A Resounding Success at the CUHK SBS 15th Anniversary Research Day 2026! We recently had the incredible opportunity to exhibit at the Chinese University of Hong Kong (CUHK) School of Biomedical Sciences (SBS) 15th Anniversary Research Day, and what a...
